loading
_Oviya MedSafe – Pharmacovigilance Consulting & Drug Safety Services

Who We Are

Oviya MedSafe is a global Pharmacovigilance Consulting & Drug Safety Services company incorporated in India in 2012 and in the United Kingdom in 2014, offering advisory and outsourced support to the pharmaceutical industry. Oviya MedSafe is backed by 50 years of collective intelligence of its founding groups and works with renowned pharmaceutical companies and marketing authorization holders in various parts of the world.

Oviya MedSafe provides end-to-end global drug safety support (combined with regulatory-compliant drug safety database access, as required) to pharmaceutical companies with mature pharmacovigilance systems. More importantly, Oviya MedSafe comprehensively consults to generic pharmaceutical companies across the globe to help them constantly evolve their pharmacovigilance departments to be in line with the regulations pertinent to their market presence.

Read More

Our Services

PHARMACOVIGILANCE CONSULTING

Oviya MedSafe offers comprehensive global pharmacovigilance consulting solutions through regulatory compliance, higher productivity and strategic drug safety outcomes. Oviya MedSafe has the broad-based experience in pharmacovigilance domain to help you address product safety concerns in a confident, proactive manner, and operating experience to provide unparalleled support to our clients.

Read More

DRUG SAFETY SERVICES

With in-depth expertise of safety reporting in clinical studies and post-marketing surveillance, Oviya MedSafe provide comprehensive global drug safety services.From individual customized stand-alone services to diverse offerings, Oviya MedSafe provides solutions specific to the requirements of our clients.

Read More

News & Events

  • 31

    Oct

    Oviya MedSafe – Cultivating Pharmacovigilance Standards Since 2012

    October 2018 edition of our newsletter

    Continue Reading...
  • 30

    Sep

    Oviya MedSafe – Pioneering Peerless Partnerships with MAHs for Focused Pharmacovigilance

    September 2018 edition of our newsletter

    Continue Reading...
  • 31

    Aug

    Oviya MedSafe – Spearheading Advocacy for Translational Pharmacovigilance

    August 2018 edition of our newsletter

    Continue Reading...
  • 31

    Jul

    Oviya MedSafe – Exemplifying Versatility in Pharmacovigilance

    July 2018 edition of our newsletter

    Continue Reading...
  • 30

    Jun

    Oviya MedSafe – Augmenting Synergies in Pharmacovigilance

    June 2018 edition of our newsletter

    Continue Reading...
  • 01

    Jun

    IndUS Drug Safety – Workshop on Indian and US FDA Pharmacovigilance Compliance – 29th Jun 2018 – Mumbai

    Press Release - 29th Jun 2018 - Mumbai

    Continue Reading...
  • 31

    May

    Oviya MedSafe – ‘IndUS Drug Safety’ Initiative & Indian Pharmacovigilance Day 2018 Conference

    May 2018 edition of our newsletter

    Continue Reading...
  • 30

    Apr

    Oviya MedSafe – Facilitating US FDA Pharmacovigilance Compliance of ANDA Holders

    April 2018 edition of our newsletter

    Continue Reading...
  • 31

    Mar

    Six Years of Oviya MedSafe & 72 Editions of Pharmacovigilance

    March 2018 edition of our newsletter

    Continue Reading...
  • 28

    Feb

    Oviya MedSafe – Personifying Integrity in Pharmacovigilance

    February 2018 edition of our newsletter

    Continue Reading...
View All